Luye Pharma Switzerland AG
Records under this name other than the patents Luye Pharma Switzerland AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Luye Pharma Switzerland AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,668,925 | Transdermal Delivery of Hormones Without the Need of Penetration Enhancers Lapsed on the fee record Ended Mar 11, 2026 · High confidence | Lapsed on the fee record | Ended Mar 11, 2026 | High confidence |
| US 8,557,279 | Transdermal Therapeutic System with Crystallization-Inhibiting Protective Film (Release Liner) Lapsed on the fee record Ended Oct 15, 2025 · High confidence | Lapsed on the fee record | Ended Oct 15, 2025 | High confidence |
| US 8,486,443 | Uv Stable Transdermal Therapeutic Plaster with a Uv Absorbing Adhesive Layer Separated from the Drug Matrix Lapsed on the fee record Ended Jul 16, 2025 · High confidence | Lapsed on the fee record | Ended Jul 16, 2025 | High confidence |
| US 9,005,653 | Transdermal Delivery of Hormones with Low Concentration of Penetration Enhancers Term ended Term ended Dec 10, 2024 · High confidence | Term ended | Term ended Dec 10, 2024 | High confidence |
| US 9,095,691 | Uv Stable Transdermal Therapeutic Plaster with a Uv Absorbing Self-Adhesive Layer Separated from the Drug Matrix Term ended Term ended May 31, 2024 · Medium confidence | Term ended | Term ended May 31, 2024 | Medium confidence |
| US 9,060,955 | Transdermal therapeutic system with crystallization-inhibiting protective film (Release liner) Lapsed on the fee record Ended Jun 23, 2023 · High confidence | Lapsed on the fee record | Ended Jun 23, 2023 | High confidence |